Edition:
United Kingdom

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

7.47EUR
4:35pm GMT
Change (% chg)

€-0.23 (-2.99%)
Prev Close
€7.70
Open
€7.68
Day's High
€7.68
Day's Low
€7.35
Volume
40,953
Avg. Vol
43,411
52-wk High
€17.94
52-wk Low
€5.61

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 2.18 -0.786
Jun '18 2.27 -1.060
FY 2017 Dec '17 1.58 -1.516
Jun '17 1.79 -1.420
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 3 8.23 13.00 4.00 11.65
Year Ending Dec-20 3 15.87 35.00 3.00 36.50
Earnings (per share)
Year Ending Dec-19 3 -3.03 -2.35 -3.54 -2.50
Year Ending Dec-20 3 -2.67 -1.98 -3.10 -1.27
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.32 32.54
P/E High - Last 5 Yrs. -- 147.72 48.15
P/E Low - Last 5 Yrs. -- 47.95 23.42
Beta 0.86 1.08 0.87
Price to Sales (TTM) 80.61 49.53 8.39
Price to Book (MRQ) -- 10.19 5.27
Price to Tangible Book (MRQ) -- 13.77 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions -- 3.74 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.70
Payout Ratio(TTM) -- 7.01 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -25.59 206.05 13.45
Sales (TTM) vs TTM 1 Yr. Ago -8.67 48.72 8.02
Sales - 5 Yr. Growth Rate 35.25 22.78 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -37.52 75.14 47.68
EPS (TTM) vs TTM 1 Yr. Ago -27.13 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.47
Capital Spending - 5 Yr. Growth Rate 81.34 9.12 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) -- 3.50 2.98
LT Debt to Equity (MRQ) -- 19.49 11.35
Total Debt to Equity (MRQ) -- 32.17 16.02
Interest Coverage (TTM) -- -43.13 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.25 52.41
Gross Margin - 5 Yr. Avg. -- 60.45 50.39
EBITD Margin (TTM) -732.50 -- --
EBITD - 5 Yr. Avg -321.23 -110.47 12.43
Operating Margin (TTM) -736.87 -185.04 5.77
Operating Margin - 5 Yr. Avg. -331.17 -126.95 8.02
Pre-Tax Margin (TTM) -727.19 -175.74 4.80
Pre-Tax Margin - 5 Yr. Avg. -337.58 -132.74 8.31
Net Profit Margin (TTM) -727.87 -182.46 1.53
Net Profit Margin - 5 Yr. Avg. -337.31 -137.13 4.72
Effective Tax Rate (TTM) -- 22.47 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 41,447 7,655,517 820,307,647
Net Income/Employee (TTM) -301,682 513,851 92,854,588
Receivable Turnover (TTM) -- 6.23 5.82
Inventory Turnover (TTM) -- 1.89 3.41
Asset Turnover (TTM) -- 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.36 10.60
Return on Assets - 5 Yr. Avg. -38.25 5.46 11.78
Return on Investment (TTM) -- 8.89 13.82
Return on Investment - 5 Yr. Avg. -46.07 6.77 15.32
Return on Equity (TTM) -- 10.00 15.25
Return on Equity - 5 Yr. Avg. -51.29 8.29 16.41
  1 Year 3 Year 5 Year
Sales % 41.28 31.92 35.25
EPS (TTM) % -27.20 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Erytech Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.30 -12.52 37 99
13 Week -7.07 -10.79 73 95
26 Week -12.20 -15.88 76 98
52 Week 35.52 13.27 99 71
YTD 76.06 59.71 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 50.87%
# of Holders: 22
Total Shares Held: 9,124,630
3 Mo. Net Change: -781,231
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 6
# Reduced Positions: 2
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.